PurposeAssays detecting donor-derived cell-free DNA (dd-cfDNA) are increasingly utilized as a non-invasive marker for rejection in solid organ transplantation. Expected baseline values and trends multiorgan transplants (MOT) have not been reported. We describe our experience with dd-cfDNA heart transplantations.MethodsThis is retrospective cohort of 26 MOT recipients who underwent concomitant e...